Literature DB >> 9118848

Outcome assessment in epilepsy: comparative responsiveness of quality of life and psychosocial instruments.

S Wiebe1, K Rose, P Derry, R McLachlan.   

Abstract

PURPOSE: Few data exist on the ability of instruments to detect within-patient change over time in epilepsy, a property referred to as responsiveness. Our aim was to compare the responsiveness of three instruments [i.e., Epilepsy Surgery Inventory-55 (ESI-55) and Washington Psychosocial Inventory (WPSI), both epilepsy specific, and Symptom Checklist-90-Revised (SCL-90-R), non-epilepsy specific].
METHODS: Instruments were administered at baseline and at 1 year in a prospective cohort of surgically (43) and medically (14) treated patients with temporal lobe epilepsy. Coefficient of Responsiveness and relative efficiency were computed for each scale and for the dimensions of mental health, physical health, and role function.
RESULTS: The ESI-55 contained the most responsive scales, whereas SCL-90-R contained the largest number of scales with moderate responsiveness. The largest number of scales with low responsiveness belonged to the WPSI. Sensitivity to between-treatment differences in change was highest for ESI-55 and SCL-90-R. The most efficient scales in detecting differences between treatment groups in the mental, physical, and role-function dimensions were ESI-55 emotional well-being, ESI-55 health perceptions, and SCL-90-R hostility, respectively.
CONCLUSIONS: Our results support the responsiveness of ESI-55 scales and suggest that SCL-90-R is a responsive tool for the assessment of psychologic function and distress in epilepsy. Comparatively, WPSI is relatively unresponsive to small or medium-size changes.

Entities:  

Mesh:

Year:  1997        PMID: 9118848     DOI: 10.1111/j.1528-1157.1997.tb01732.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  12 in total

1.  A comparison of responsiveness indices in multiple sclerosis patients.

Authors:  L E Pfennings; H M van der Ploeg; L Cohen; C H Polman
Journal:  Qual Life Res       Date:  1999-09       Impact factor: 4.147

2.  The Symptom Check-List-90-R (SCL-90-R): a German validation study.

Authors:  N Schmitz; N Hartkamp; J Kiuse; G H Franke; G Reister; W Tress
Journal:  Qual Life Res       Date:  2000-03       Impact factor: 4.147

3.  On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation.

Authors:  C B Terwee; F W Dekker; W M Wiersinga; M F Prummel; P M M Bossuyt
Journal:  Qual Life Res       Date:  2003-06       Impact factor: 4.147

4.  Quality of life among Iranian refugees resettled in Sweden.

Authors:  Mehdi Ghazinour; Jörg Richter; Martin Eisemann
Journal:  J Immigr Health       Date:  2004-04

Review 5.  The "burden of normality": concepts of adjustment after surgery for seizures.

Authors:  S Wilson; P Bladin; M Saling
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-05       Impact factor: 10.154

6.  Psychiatric Symptoms in Refractory Epilepsy During the First Year After Surgery.

Authors:  Sònia Ramos-Perdigués; Eva Baillés; Anna Mané; Mar Carreño; Antonio Donaire; Jordi Rumià; Nuria Bargalló; Teresa Boget; Xavier Setoain; Manuel Valdés; Luís Pintor
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

7.  Clinically important change in quality of life in epilepsy.

Authors:  S Wiebe; S Matijevic; M Eliasziw; P A Derry
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-08       Impact factor: 10.154

8.  Psychosomatic symptom profiles in patients with restless legs syndrome.

Authors:  Jung Bin Kim; Yong Seo Koo; Mi-Yeon Eun; Kun-Woo Park; Ki-Young Jung
Journal:  Sleep Breath       Date:  2013-01-23       Impact factor: 2.816

Review 9.  Patient-reported upper extremity outcome measures used in breast cancer survivors: a systematic review.

Authors:  Shana Harrington; Lori A Michener; Tiffany Kendig; Susan Miale; Steven Z George
Journal:  Arch Phys Med Rehabil       Date:  2013-08-06       Impact factor: 3.966

Review 10.  Patient Reported Outcome (PRO) assessment in epilepsy: a review of epilepsy-specific PROs according to the Food and Drug Administration (FDA) regulatory requirements.

Authors:  Annabel Nixon; Cicely Kerr; Katie Breheny; Diane Wild
Journal:  Health Qual Life Outcomes       Date:  2013-03-11       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.